Susquehanna Fundamental Investments’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60.8K | Sell |
27,642
-215,855
| -89% | -$475K | ﹤0.01% | 702 |
|
|
2025
Q1 | $282K | Sell |
243,497
-28,933
| -11% | -$33.6K | ﹤0.01% | 956 |
|
|
2024
Q4 | $346K | Buy |
+272,430
| New | +$346K | ﹤0.01% | 916 |
|
|
2024
Q1 | – | Sell |
-65,463
| Closed | -$663K | – | 674 |
|
|
2023
Q4 | $663K | Sell |
65,463
-53,824
| -45% | -$545K | 0.67% | 26 |
|
|
2023
Q3 | $930K | Hold |
119,287
| – | – | 0.06% | 204 |
|
|
2023
Q2 | $982K | Sell |
119,287
-76,215
| -39% | -$627K | 0.04% | 335 |
|
|
2023
Q1 | $1.42M | Hold |
195,502
| – | – | 0.03% | 455 |
|
|
2022
Q4 | $1.73M | Buy |
+195,502
| New | +$1.73M | 0.03% | 519 |
|
|
2021
Q2 | – | Sell |
-11,642
| Closed | -$489K | – | 1684 |
|
|
2021
Q1 | $489K | Buy |
+11,642
| New | +$489K | 0.01% | 1148 |
|
|
2020
Q4 | – | Sell |
-28,600
| Closed | -$803K | – | 1524 |
|
|
2020
Q3 | $803K | Hold |
28,600
| – | – | 0.02% | 722 |
|
|
2020
Q2 | $846K | Buy |
+28,600
| New | +$846K | 0.04% | 494 |
|